ANTI-BLYS BIOLOGICS IN THE B-CELL TARGETED THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS: FOCUS ON EFFICACY AND SAFETY OF BELIMUMAB, ATACICEPT AND TABALUMAB.

ANTI-BLYS BIOLOGICS IN THE B-CELL TARGETED THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS: FOCUS ON EFFICACY AND SAFETY OF BELIMUMAB, ATACICEPT AND TABALUMAB.

Dulficar, Fathima Fazla; Dias, Sajani
URI: http://220.247.247.85:8081/handle/123456789/37391
Date: 2019-06-15

Description:

Biology, BMS School of Science, Sri Lanka

Show full item record

Files in this item

Icon
Name: Fathima Fazla.pdf
Size: 1.111Mb
Format: PDF
View/Open

This item appears in the following Collection(s)

Search


Browse

My Account